Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Y-Mabs Therapeutics Inc (YMAB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2019	12-2018	12-2017	12-2016	12-2006
Assets
Current Assets
Cash & Cash Equivalents	207,136	147,871	90,515	16,903	N/A
Other current assets	4,819	3,661	840	358	0
TOTAL	$211,955	$151,532	$91,355	$17,261	$N/A

Non-Current Assets
PPE Net	2,052	205	N/A	N/A	N/A
Other Non-Current Assets	2,359	187	772	0	0
TOTAL	$4,411	$392	$772	$N/A	$N/A

Total Assets	$216,366	$151,924	$92,127	$17,261	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	8,520	5,872	5,909	2,227	0
Accrued Expenses	4,550	3,251	2,016	748	N/A
TOTAL	$13,586	$9,123	$7,925	$2,975	$N/A

Non-Current Liabilities
Other Non-Current Liabilities	3,877	2,274	2,050	2,225	0
TOTAL	$3,877	$2,274	$2,050	$2,225	$N/A

Total Liabilities	$17,463	$11,397	$9,975	$5,200	$N/A

Shareholders' Equity
Shares Outstanding, K	39,757	34,194	N/A	N/A	N/A
Common Shares	4	3	3	2	N/A
Retained earnings	-165,863	-84,835	-41,561	-22,400	N/A
Other shareholders' equity	50	7	-169	30	0
TOTAL	$198,903	$140,527	$82,152	$12,061	$N/A

Total Liabilities And Equity	$216,366	$151,924	$92,127	$17,261	$0